𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Transdermal nitroglycerin: clinical and pharmacokinetic consequences of renewing the patch and the application site

✍ Scribed by T. O. Klemsdal; H. H. Mundal; J. E. Bredesen; K. Gjesdal

Book ID
105922679
Publisher
Springer
Year
1997
Tongue
English
Weight
124 KB
Volume
52
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Association of transdermal nitroglycerin
Association of transdermal nitroglycerin to vasopressin infusion in the treatment of variceal hemorrhage: A placebo-controlled clinical trial
✍ Jaime Bosch; Roberto J. Groszmann; Joan C. García-Pagán; Josep Terés; Guadalupe 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 797 KB

The aim of this study was to evaluate, using a doubleblind technique, the efficacy of the association of transdermal nitroglycerin to vasopressin infusion for the treatment of variceal bleeding. Sixty-nine cirrhotic patients with active variceal bleeding were randomly allocated to receive vasopressi

Morphological investigations of a porous
Morphological investigations of a porous aluminum oxide ceramic and the consequences for clinical application
✍ M. Forgon; E. Mammel; K. Trombitás; L. Kacsalova; I. Dráveczki 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 561 KB

The ingrowth of bone and the tissue compatibility of a Hungarian aluminum-oxide ceramic have been investigated in animal experiments by microscopic section, by electron microscopy, and with energy-dispersion X-ray microanalysis. Surrounding bone grew into the 100- to 500-micron pores of the porous c

Improving the pharmacokinetic parameter
Improving the pharmacokinetic parameter measurement in dynamic contrast-enhanced MRI by use of the arterial input function: Theory and clinical application
✍ Xiangyu Yang; Jiachao Liang; Johannes T. Heverhagen; Guang Jia; Petra Schmalbroc 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 715 KB

## Abstract One of the most powerful features of the dynamic contrast‐enhanced (DCE) MRI technique is its capability to quantitatively measure the physiological or pathophysiological environments assessed by the passage of contrast agent by means of model‐based pharmacokinetic analysis. The widely